SOPH Stock Summary and Trading Ideas (Sophia Genetics SA - | NASDAQ:SOPH)

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Sophia Genetics SA - trades on the NASDAQ stock market under the symbol SOPH.

As of July 23, 2026, SOPH stock price declined to $6.05 with 391,102 million shares trading.

SOPH has a beta of 1.08, meaning it tends to be more sensitive to market movements. SOPH has a correlation of 0.06 to the broad based SPY ETF.

SOPH has a market cap of $507.57 million. This is considered a Small Cap stock.

Last quarter Sophia Genetics SA - reported $22 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.03.

In the last 3 years, SOPH traded as high as $7.37 and as low as $2.13.

The top ETF exchange traded funds that SOPH belongs to (by Net Assets): ONEQ, MEDI, GNMX.

SOPH has outperformed the market in the last year with a price return of +76.4% while the SPY ETF gained +18.6%. SOPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.9% and +9.8%, respectively, while the SPY returned +4.1% and -1.0%, respectively.

SOPH support price is $6.12 and resistance is $6.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SOPH shares will trade within this expected range on the day.